Anna Karjalainen

1.4k total citations
38 papers, 930 citations indexed

About

Anna Karjalainen is a scholar working on Rheumatology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine. According to data from OpenAlex, Anna Karjalainen has authored 38 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 10 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Anna Karjalainen's work include Rheumatoid Arthritis Research and Therapies (17 papers), Menopause: Health Impacts and Treatments (7 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Anna Karjalainen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (17 papers), Menopause: Health Impacts and Treatments (7 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Anna Karjalainen collaborates with scholars based in Finland, United Kingdom and Japan. Anna Karjalainen's co-authors include Jorma Heikkinen, Markku J. Savolainen, Marjatta Leirisalo‐Repo, Hannu Kautiainen, Y. Antero Kesäniemi, Markku Korpela, Kari Puolakka, Timo Möttönen, Pekka Hannonen and A. Hirvonen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Cleaner Production and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Anna Karjalainen

36 papers receiving 883 citations

Peers

Countries citing papers authored by Anna Karjalainen

Since Specialization

Citations

This map shows the geographic impact of Anna Karjalainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Karjalainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Karjalainen more than expected).

Fields of papers citing papers by Anna Karjalainen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Karjalainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Karjalainen. The network helps show where Anna Karjalainen may publish in the future.

Co-authorship network of co-authors of Anna Karjalainen

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Karjalainen. A scholar is included among the top collaborators of Anna Karjalainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Karjalainen. Anna Karjalainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immigrant Nurses and Allied Professionals Seeking to Validate Their Qualification in Finland 2024 ·European Journal of Education ·(unknown), Anna Karjalainen	0
2	Acrokeratosis Paraneoplastica-like Findings as a Manifestation of Systemic Lupus Erythematosus 2018 ·Acta Dermato Venereologica ·Laura Huilaja, (unknown), Anna Karjalainen, Kaisa Tasanen	1
3	Patient-reported outcomes as predictors of remission in early rheumatoid arthritis patients treated with tight control treat-to-target approach 2017 ·Rheumatology International ·(unknown), (unknown), Kari Puolakka, Hannu Kautiainen, Anna Karjalainen, (unknown), Timo Yli‐Kerttula, Marjatta Leirisalo‐Repo, Vappu Rantalaiho	11
4	Cytokine data obtained from synovial stromal cells of patients with rheumatoid arthritis or osteoarthritis 2017 ·Data in Brief ·Johanna Huhtakangas, Johanna Veijola, Sanna Turunen, Anna Karjalainen, Maarit Valkealahti, (unknown), (unknown), Olli Vuolteenaho, Petri Lehenkari	4
5	Impact of physicians’ adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial 2015 ·Scandinavian Journal of Rheumatology ·(unknown), Kari Puolakka, Hannu Kautiainen, Harri Blåfield, (unknown), Kirsti Ilva, Oili Kaipiainen‐Seppänen, Anna Karjalainen, Markku Korpela, Heikki Valleala, Marjatta Leirisalo‐Repo, Vappu Rantalaiho, (unknown)	18
6	Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study) 2012 ·Annals of the Rheumatic Diseases ·Marjatta Leirisalo‐Repo, Hannu Kautiainen, Leena Laasonen, Markku Korpela, Markku Kauppi, Oili Kaipiainen‐Seppänen, Riitta Luosujärvi, Reijo Luukkainen, Anna Karjalainen, Harri Blåfield, Toini Uutela, Kirsti Ilva, Heikki Julkunen, Leena Paimela, Kari Puolakka, Eeva Moilanen, Pekka Hannonen, Timo Möttönen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	69
7	Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial 2010 ·Arthritis Research & Therapy ·Vappu Rantalaiho, Markku Korpela, Leena Laasonen, Hannu Kautiainen, Salme Järvenpää, Pekka Hannonen, Marjatta Leirisalo‐Repo, Harri Blåfield, Kari Puolakka, Anna Karjalainen, Timo Möttönen, (unknown)	78
8	Low-density lipoprotein clearance in patients with chronic renal failure 2009 ·Nephrology Dialysis Transplantation ·Helena Kastarinen, Sohvi Hörkkö, Heikki Kauma, Anna Karjalainen, Markku J. Savolainen, Y. Antero Kesäniemi	7
9	Rheumatoid Atlantoaxial Subluxation Can Be Prevented by Intensive Use of Traditional Disease Modifying Antirheumatic Drugs 2009 ·The Journal of Rheumatology ·Markku Kauppi, Marko H. Neva, Kari Laiho, Hannu Kautiainen, Reijo Luukkainen, Anna Karjalainen, Pekka Hannonen, Marjatta Leirisalo‐Repo, Markku Korpela, Kirsti Ilva, Timo Möttönen, (unknown)	37
10	Characterization of metabolic interrelationships and in silico phenotyping of lipoprotein particles using self-organizing maps 2009 ·Journal of Lipid Research ·(unknown), Sanna Mäkelä, Ville‐Petteri Mäkinen, Anna Karjalainen, Johanna Liinamaa, Kimmo Kaski, Markku J. Savolainen, Minna L. Hannuksela, Mika Ala‐Korpela	10
11	Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women 2008 ·Metabolism ·Anne Kunnari, Merja Santaniemi, (unknown), Anna Karjalainen, Jorma Heikkinen, Olavi Ukkola, Y. Antero Kesäniemi	27
12	Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study 2006 ·Lara D. Veeken ·(unknown), (unknown), R. Takalo, Airi Jartti, Raija K. Niemelä, Anna Karjalainen, Marianne Haapea, Irma Soini, Osmo Tervonen, Markku Hakala	77
13	Biological treatment in rheumatic diseases: results from a longitudinal surveillance: adverse events 2006 ·Rheumatology International ·Liisa Konttinen, Visa Honkanen, T. Uotila, (unknown), (unknown), (unknown), Kari Puolakka, (unknown), Anna Karjalainen, Reijo Luukkainen, Dan Nordström, (unknown)	17
14	Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis 2006 ·Lara D. Veeken ·Minna Koivula, (unknown), Esko Alasaarela, Anna Karjalainen, Markku Hakala, Juha Risteli	9
15	Effects of estrogen replacement therapy on natriuretic peptides and blood pressure 2003 ·Maturitas ·Anna Karjalainen, Heikki Ruskoaho, Olli Vuolteenaho, Jorma Heikkinen, (unknown), Markku J. Savolainen, Y. Antero Kesäniemi	32
16	Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism 2001 ·Clinical Endocrinology ·Anna Karjalainen, Marita Paassilta, Jorma Heikkinen, (unknown), Markku J. Savolainen, Y. Antero Kesäniemi	39
17	Regulation of plasma low density lipoprotein levels in postmenopausal women 2000 ·Atherosclerosis ·Anna Karjalainen, Jorma Heikkinen, Markku J. Savolainen, (unknown), Y. Antero Kesäniemi	5
18	Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels 2000 ·Atherosclerosis ·Marita Paassilta, Anna Karjalainen, Kari Kervinen, Markku J. Savolainen, Jorma Heikkinen, (unknown), Y. Antero Kesäniemi	34
19	Metabolic changes induced by peroral oestrogen and transdermal oestradiol gel therapy 1997 ·BJOG An International Journal of Obstetrics & Gynaecology ·Anna Karjalainen, Jorma Heikkinen, Markku J. Savolainen, (unknown), (unknown), Y. Antero Kesäniemi	19
20	Improved metabolic control in patients with non‐insulin‐dependent diabetes mellitus is associated with a slower accumulation of glycation products in collagen* 1995 ·European Journal of Clinical Investigation ·Pasi Salmela, Aarne Oikarinen, Olavi Ukkola, Anna Karjalainen, Markku Linnaluoto, Raija Puukka, Lasse Ryhänen	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact